Gemini has secured a major regulatory milestone in the United States after the Commodity Futures Trading Commission approved its affiliate, Gemini Olympus, LLC, as a derivatives clearing organization (DCO). The approval gives the crypto exchange direct control over the clearing of its own regulated derivatives products, reducing its reliance on outside clearing providers and moving the company closer to a fully integrated CFTC-regulated market structure.
The registration, approved by Commission order on April 29, 2026, covers fully collateralized futures, options on futures, and swaps. Gemini co-founder Cameron Winklevoss announced the decision on April 30. For Gemini, the DCO designation is more than a licensing win: it adds control over one of the most important layers of market infrastructure, including margin management, collateral handling, settlement, and netting.
A Shift Away From Third-Party Clearing
Before obtaining DCO status, Gemini Titan had relied on third-party clearing arrangements, including structures supported by no-action relief and services involving QC Clearing LLC. With Gemini Olympus now recognized as a clearinghouse under CFTC oversight, the company can bring those post-trade functions in house.
That is a meaningful operational and strategic change. A DCO acts as a central counterparty, stepping between trading participants and substituting its own credit for that of the original counterparties. In practice, this role is essential to how regulated derivatives markets function. It helps manage default risk, administers margin requirements, handles collateral, and ensures trades are processed and settled under a supervised framework.
For Gemini, internalizing those responsibilities means less dependence on external infrastructure and more control over how new products are launched and supported. It also gives the company a stronger foundation to expand beyond its existing event-based offerings.
Building on Gemini’s Earlier DCM Approval
The DCO approval follows another major regulatory step for the company. In December 2025, CFTC approval was granted for Gemini Titan, LLC to operate as a Designated Contract Market (DCM). That authorization came after a five-year application process that began on March 10, 2020.
The DCM license enabled Gemini to launch Gemini Predictions, a regulated event contracts platform available to U.S. users through the Gemini app. The product introduced prediction markets with binary and variable payout structures, placing Gemini into a segment of the market that has attracted growing public and regulatory attention.
Now, with both DCM and DCO registrations in place across affiliated entities, Gemini has assembled two of the most important components of a CFTC-regulated derivatives stack. The combination allows a platform not only to list and operate a regulated market, but also to clear those products within the same broader regulatory framework.
One Piece Missing: FCM Registration
Despite the progress, Gemini has not yet completed the full set of licenses often associated with a vertically integrated regulated derivatives venue. The remaining missing piece is a Futures Commission Merchant (FCM) registration, which covers brokerage and customer-facing intermediation functions. According to the report, Gemini is working toward that registration as well.
If Gemini ultimately adds FCM status to its existing DCM and DCO structure, it would be positioned to manage trading, clearing, and brokerage across CFTC-regulated products under one umbrella. That would give the company a more comprehensive infrastructure model and put it in a stronger position to compete with established and emerging regulated derivatives operators.
Winklevoss described the DCO as a “core building block” of Gemini’s broader super app vision, suggesting that the company sees regulated derivatives infrastructure as central to serving users’ present and future financial needs on a single platform.
What the Approval Means for Product Expansion
For U.S. customers, the immediate implication is that Gemini’s prediction markets can now be cleared internally rather than through a third party. More broadly, the DCO approval opens the path for Gemini Titan to expand its product suite beyond event contracts. The report indicates that futures, options, and perpetual-style products are expected to follow as the company broadens its regulated derivatives offering.
This is significant because clearing capability is often a gating factor in derivatives expansion. A venue may be able to design products and secure listing authority, but without a clearing solution, scaling regulated derivatives can remain difficult. By bringing that function in house, Gemini gains greater flexibility over product design, launch timing, and operating structure.
The CFTC stated that Gemini Olympus met the requirements of the Commodity Exchange Act and relevant Commission rules. The summary of the approval did not identify conditions beyond standard compliance with the core principles that apply to DCOs. That detail matters because it suggests the registration was processed within the expected regulatory framework rather than through a bespoke or exceptional arrangement.
Competitive Pressure in the U.S. Regulated Market
The approval also lands in an increasingly competitive market for regulated crypto and event-based derivatives in the United States. The report points directly to Kraken’s acquisition of Bitnomial last year, a move that gave Kraken access to a combined DCM, DCO, and FCM structure. At the same time, prediction market operators such as Kalshi and Polymarket have continued to broaden their regulated and quasi-regulated market reach.
Against that backdrop, Gemini’s new clearing capability narrows an important infrastructure gap. It does not yet place the company fully on equal footing with platforms that already have all three components, but it clearly improves Gemini’s standing in the race to build a scalable, compliant U.S. derivatives franchise.
There is also a timing element worth noting. Gemini Olympus filed for DCO registration on December 17, 2025, roughly one week after Gemini Titan’s DCM approval. The approximately four-month review period appears relatively efficient compared with earlier years, when crypto firms often faced longer waits and greater uncertainty in navigating federal approvals.
Regulatory Progress, Even as Broader Scrutiny Persists
While the DCO approval is a positive development for Gemini, it comes against a more complicated legal and policy backdrop for prediction markets and crypto platforms. The source article notes that New York Attorney General Letitia James has sued Coinbase and Gemini over allegations tied to unlicensed prediction markets and underage gambling law violations. That issue is separate from the CFTC registration process, but it underscores that regulatory progress in one channel does not eliminate scrutiny from other authorities or jurisdictions.
Still, the CFTC decision stands as a concrete advancement in Gemini’s federal regulatory posture. The combination of DCM and DCO licenses gives the company the ability to design, list, and clear its own regulated derivatives products within one supervised structure. If the company succeeds in adding FCM registration, it would complete a model that many market operators view as the ideal full-stack configuration for running a modern U.S. derivatives platform.
For now, the approval of Gemini Olympus signals that Gemini is accelerating its push into regulated derivatives infrastructure. With internal clearing now in place and additional product expansion expected, the exchange is positioning itself to play a larger role in the next phase of the U.S. crypto derivatives market.

